Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Exenatide

Brand: Bydureon®
NICE TA: 
Indication: Type 2 diabetes (NICE NG28)
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

NICE TA248 replaced by NICE NG28
The LMMG recommends Bydureon® as a 1st line GLP‑1 agonist.

Recommendation

LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care

Supporting documents:

NICE NG28 Type 2 diabetes in adults: management

Algorithm For Antihyperglycaemic Therapy In Adults With Type II (Version 1.4) (585.4 KiB)

 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green

Green

Green

Green